- Home
- EVF vs WHWK Comparison
EVF vs WHWK Comparison
Compare EVF & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- WHWK
- Stock Information
- Founded
- EVF 1998
- WHWK 2007
- Country
- EVF United States
- WHWK United States
- Employees
- EVF N/A
- WHWK N/A
- Industry
- EVF Investment Managers
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- EVF Finance
- WHWK Health Care
- Exchange
- EVF Nasdaq
- WHWK Nasdaq
- Market Cap
- EVF 102.9M
- WHWK 82.4M
- IPO Year
- EVF N/A
- WHWK N/A
- Fundamental
- Price
- EVF $5.59
- WHWK $1.74
- Analyst Decision
- EVF
- WHWK
- Analyst Count
- EVF 0
- WHWK 0
- Target Price
- EVF N/A
- WHWK N/A
- AVG Volume (30 Days)
- EVF 93.3K
- WHWK 118.0K
- Earning Date
- EVF 01-01-0001
- WHWK 08-15-2025
- Dividend Yield
- EVF 10.68%
- WHWK N/A
- EPS Growth
- EVF N/A
- WHWK N/A
- EPS
- EVF 0.94
- WHWK 0.91
- Revenue
- EVF N/A
- WHWK $27,775,000.00
- Revenue This Year
- EVF N/A
- WHWK $49.83
- Revenue Next Year
- EVF N/A
- WHWK N/A
- P/E Ratio
- EVF $6.74
- WHWK $1.90
- Revenue Growth
- EVF N/A
- WHWK 16.51
- 52 Week Low
- EVF $5.20
- WHWK $1.21
- 52 Week High
- EVF $6.84
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- EVF 39.58
- WHWK N/A
- Support Level
- EVF $5.60
- WHWK N/A
- Resistance Level
- EVF $5.64
- WHWK N/A
- Average True Range (ATR)
- EVF 0.03
- WHWK 0.00
- MACD
- EVF -0.00
- WHWK 0.00
- Stochastic Oscillator
- EVF 0.00
- WHWK 0.00
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.